These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 493995)

  • 1. Noncycling tumor cells are sensitive targets for the antiproliferative activity of human interferon.
    Horoszewicz JS; Leong SS; Carter WA
    Science; 1979 Nov; 206(4422):1091-3. PubMed ID: 493995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effect on interferon on a Burkitt's lymphoma cell line.
    Leandersson T; Lundgren E
    Exp Cell Res; 1980 Dec; 130(2):421-6. PubMed ID: 6161021
    [No Abstract]   [Full Text] [Related]  

  • 3. Proliferation inhibitory effect of human alpha interferon on primary explants of Burkitt lymphoma: inverse relationship to patient survival.
    Ernberg I; Einhorn S; Strander H; Klein G
    Biomedicine; 1981 Nov; 35(6):190-3. PubMed ID: 6175356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-induced alterations in membrane functions and the growth of Daudi lymphoma and Friend leukemia cells.
    Siegler E; Schaefer A; Bilello JA
    Biosci Rep; 1982 Aug; 2(8):605-8. PubMed ID: 6182931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell growth regulation during density inhibition and interferon treatment.
    Leandersson T; Lundgren E
    Exp Cell Res; 1982 Mar; 138(1):167-74. PubMed ID: 6175527
    [No Abstract]   [Full Text] [Related]  

  • 6. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
    Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki-67 as a marker for cell cycle regulation by interferon.
    Lundblad D; Landberg G; Roos G; Lundgren E
    Anticancer Res; 1991; 11(6):2131-6. PubMed ID: 1723263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral effects of interferon on a somatic cell hybrid between two Burkitt's lymphoma cell lines of different interferon sensitivities.
    Lidin B; Lamon EW
    Infect Immun; 1982 May; 36(2):847-9. PubMed ID: 6177642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-proliferative effects of interferons on Daudi Burkitt lymphoma cells: induction of cell differentiation and loss of response to autocrine growth factors.
    Exley R; Gordon J; Nathan P; Walker L; Clemens MJ
    Int J Cancer; 1987 Jul; 40(1):53-7. PubMed ID: 2439466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiproliferative effect of interferon inducers].
    Lavrukhina LA; Ershov FI
    Vopr Virusol; 1985; 30(4):446-9. PubMed ID: 2414927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells.
    Borden EC; Hogan TF; Voelkel JG
    Cancer Res; 1982 Dec; 42(12):4948-53. PubMed ID: 7139598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is interferon tissue specific?- Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines.
    Einhorn S; Strander H
    J Gen Virol; 1977 Jun; 35(3):573-7. PubMed ID: 267737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic and binding activities of IFN-alpha subtypes in ACHN human renal cell carcinoma cells and Daudi Burkitt's lymphoma cells.
    Yamaoka T; Kojima S; Ichi S; Kashiwazaki Y; Koide T; Sokawa Y
    J Interferon Cytokine Res; 1999 Dec; 19(12):1343-9. PubMed ID: 10638703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of human interferon on normal and neoplastic T- and B-cell lymphocytes.
    Attallah AM; Fleischer T; Neefe JR; Kazakis A; Yeatman TJ
    Ann N Y Acad Sci; 1980; 350():245-53. PubMed ID: 6165279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor.
    Orlowski RZ; Eswara JR; Lafond-Walker A; Grever MR; Orlowski M; Dang CV
    Cancer Res; 1998 Oct; 58(19):4342-8. PubMed ID: 9766662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol ester-induced inhibition of proliferation of Daudi Burkitt's lymphoma cells by impairment of cytokinesis.
    Menaya J; Clemens MJ
    Exp Cell Res; 1991 Jun; 194(2):260-6. PubMed ID: 2026178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiviral and antiproliferative activity of human interferons and their induction of 2',5'-oligoadenylate synthetase].
    Krispin TI; Itkes AV; Balandin IG; Solov'eva MF; Kuznetsov VP
    Mol Gen Mikrobiol Virusol; 1986 Apr; (4):42-6. PubMed ID: 2432419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
    Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
    Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative effect of (2'-5') oligoadenylate distinct from that of interferon in lymphoid cells.
    Leanderson T; Nordfelth R; Lundgren E
    Biochem Biophys Res Commun; 1982 Jul; 107(2):511-7. PubMed ID: 6181787
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the effects of alpha and beta interferons on the proliferation and volume of human tumor cells (HeLa-S3, Daudi, P3HR-1).
    Pfeffer LM; Tamm I
    J Interferon Res; 1983; 3(4):395-408. PubMed ID: 6672112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.